SRIT India is scheduled to begin its initial public offering on September 28, 2026, offering up to 1.68 crore new shares. At the ₹130 upper price band, the offer would raise ₹218.4 crore before issue expenses. Public bidding is scheduled to end on September 30.
This is a pre-opening report, prepared before the Indian bidding session. It does not report live demand, an allotment outcome or a completed listing.
Price band and application cost
The RR Finance issue calendar lists a ₹123–130 band and a 115-share bid lot. One lot therefore represents ₹14,145 at the lower band or ₹14,950 at the upper band. These are application-value calculations, not a forecast of what the shares will trade at.
The calendar indicates October 1 for allotment finalisation and October 6 for listing. Those are expected milestones, subject to the final exchange and registrar notices.
Where the new capital would go
The company’s abridged prospectus identifies product modernisation and redevelopment, working capital, unidentified acquisitions or other strategic initiatives, and general corporate purposes as proposed uses. There is no offer-for-sale component. Proposed listings are on NSE and BSE; KFin Technologies is the registrar.
SRIT’s business overview describes technology work across healthcare, electronic governance and telecom infrastructure. The commercial exposure is therefore to delivering and maintaining systems, not simply selling one consumer software product.
The concentration risk behind the growth story
Government-tender projects accounted for 89.41% of FY2026 operating revenue, according to the abridged prospectus. Its five largest customers contributed 75.55%. It also flags dependence on subcontractors and the cash-flow implications of receivables and contract assets.
CapKet analysis: Investors evaluating this offer should distinguish reported sales from cash collected. A large project win can support future activity, but completion milestones, subcontractor delivery and customer payments determine how readily that activity turns into usable cash. Fresh capital does not remove those execution risks.
What this report does not establish
No grey-market premium, subscription multiple or expected listing return is asserted. An IPO application does not guarantee allotment or profit. Read the full RHP and subsequent notices on the issuer’s IPO documents page before making a decision. This is general financial news, not a recommendation to apply.